China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Combined Prediction of Neurodevelopmental Outcomes after Intraventricular Hemorrhage in Extremely Preterm Infants by Multi-Omics and Multimodal MRI'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133086

Registration Time: 2026/09/21

Type: Observational study

Primary Sponsor: The Third Affiliated Hospital of Zhengzhou University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=324759

Published by HT Digital Content Services with permission from Health Daily Digest....